CMO

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Checkpoint Therapeutics, Inc. (CKPT)

Retrieved on: 
Monday, April 8, 2024
Radiation, CKPT, District court, Patient, News, Checkpoint, Complaint, CMO, FDA, BLA, Person

The Complaint in the lawsuit seeks to recover damages for the Company’s investors under the federal securities laws.

Key Points: 
  • The Complaint in the lawsuit seeks to recover damages for the Company’s investors under the federal securities laws.
  • The Complaint alleges that Defendants made materially false and misleading statements regarding the Company’s business, operations, and compliance policies.
  • If you wish to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq.
  • of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected] .

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Checkpoint Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – CKPT

Retrieved on: 
Monday, April 8, 2024
Radiation, CKPT, Prior, Biologics license application, District court, Patient, News, Ext, Acquisition, LLP, Checkpoint, Complaint, Pomerantz, CMO, Action Replay, Food, FDA, BLA, Court, Person

NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Checkpoint Therapeutics, Inc. (“Checkpoint” or the “Company”) (NASDAQ: CKPT) and certain officers.

Key Points: 
  • NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Checkpoint Therapeutics, Inc. (“Checkpoint” or the “Company”) (NASDAQ: CKPT) and certain officers.
  • To discuss this action, contact Danielle Peyton at [email protected] or 646-581-9980 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against Checkpoint Therapeutics, Inc. (CKPT)

Retrieved on: 
Monday, April 8, 2024
Radiation, CKPT, Patient, SAN, News, LLP, Acquisition, Checkpoint, CMO, FDA, BLA, Person, Pharmaceutical industry

SAN DIEGO, April 07, 2024 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) securities between March 10, 2021 and December 15, 2023.

Key Points: 
  • SAN DIEGO, April 07, 2024 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) securities between March 10, 2021 and December 15, 2023.
  • For more information, submit a form , email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.
  • A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation.
  • If you choose to take no action, you can remain an absent class member.

Rush Street Interactive Appoints Brian Sapp as Chief Marketing Officer

Retrieved on: 
Monday, April 8, 2024
Growth, Sport, Digital, Electronic publishing, Acquisition, Rec Room, Senior, Warner Bros. Interactive Entertainment, Creativity, CMO, RSI, Marketing, WB

CHICAGO, April 08, 2024 (GLOBE NEWSWIRE) -- Rush Street Interactive, Inc. (NYSE: RSI) (“RSI”), a leading online casino and sports betting company in the United States and the rest of the Americas, today announced the appointment of Brian Sapp to the newly-created role of Chief Marketing Officer.

Key Points: 
  • CHICAGO, April 08, 2024 (GLOBE NEWSWIRE) -- Rush Street Interactive, Inc. (NYSE: RSI) (“RSI”), a leading online casino and sports betting company in the United States and the rest of the Americas, today announced the appointment of Brian Sapp to the newly-created role of Chief Marketing Officer.
  • Upon his appointment, Brian expressed his enthusiasm, stating, "I am thrilled to join Rush Street Interactive at a time when the company has such strong momentum.
  • Brian's appointment underscores Rush Street Interactive's commitment to innovation and strategic growth in the rapidly evolving online gaming landscape.
  • His extensive experience and proven leadership will undoubtedly propel Rush Street Interactive to new heights of success as new markets come online and existing markets continue to mature.

eShare Appoints Niki Sotiropoulou as Chief Marketing Officer

Retrieved on: 
Wednesday, April 3, 2024
Unicorn, CMO, Marketing, Software as a service, B2C

WALTHAM, Mass., April 03, 2024 (GLOBE NEWSWIRE) -- eShare, a trailblazer in redefining how enterprises share and collaborate externally, is delighted to announce the appointment of Niki Sotiropoulou as its new Chief Marketing Officer (CMO).

Key Points: 
  • WALTHAM, Mass., April 03, 2024 (GLOBE NEWSWIRE) -- eShare, a trailblazer in redefining how enterprises share and collaborate externally, is delighted to announce the appointment of Niki Sotiropoulou as its new Chief Marketing Officer (CMO).
  • With an extensive career of over twenty years in marketing, Niki brings invaluable expertise in B2B and B2C marketing strategies to eShare, marking a significant addition to the leadership team.
  • Before joining eShare, Niki served as the Chief Marketing Officer (CMO) at viva.com, a pioneering Tech Bank renowned for being the first Greek Unicorn.
  • In this role, Niki was instrumental in laying the foundations and operational frameworks for a pan-European marketing team, spanning across 24 countries.

ADARx Pharmaceuticals Appoints Dr. Chris Storgard as Chief Medical Officer

Retrieved on: 
Tuesday, April 2, 2024
Clinical research, Molecular medicine, AstraZeneca, Entrepreneurship, Patient, SAN, Mayo Clinic, Research, RNA, Bachelor of Science, Lead, University, MD, Senior, Sympathetic nervous system, Biology, Therapy, Destiny, Division, CMO, Amgen, DSM-IV codes, Pharmaceutical industry

SAN DIEGO, April 02, 2024 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. (ADARx), a clinical stage biotechnology company developing next generation RNA therapeutics, today announced the appointment of Chris Storgard, M.D., as Chief Medical Officer (CMO).

Key Points: 
  • SAN DIEGO, April 02, 2024 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. (ADARx), a clinical stage biotechnology company developing next generation RNA therapeutics, today announced the appointment of Chris Storgard, M.D., as Chief Medical Officer (CMO).
  • As CMO, Dr. Storgard will lead Clinical Research, Clinical Operations, Biometrics, Pharmacovigilance and Medical Affairs.
  • Dr. Storgard has a BSc in biology and an MD from the University of Saskatchewan in Canada.
  • Dr. Storgard completed a fellowship in rheumatology at Scripps Clinic and Research Center in San Diego, CA.

LeaseCrunch Joins Aprio Firm Alliance Affiliate Relationship Program

Retrieved on: 
Tuesday, April 2, 2024
Growth, Partnership, ASC, CMO, GASB, CPA

MILWAUKEE, April 02, 2024 (GLOBE NEWSWIRE) -- LeaseCrunch LLC , a leading accounting software company, has joined the Aprio Firm Alliance Affiliate Relationship Program and will be a key sponsor at the annual conference.

Key Points: 
  • MILWAUKEE, April 02, 2024 (GLOBE NEWSWIRE) -- LeaseCrunch LLC , a leading accounting software company, has joined the Aprio Firm Alliance Affiliate Relationship Program and will be a key sponsor at the annual conference.
  • The Aprio Firm Alliance is a national accounting firm association designed by accounting professionals for forward-thinking CPA firms.
  • Aprio Firm Alliance plays a crucial role in providing CPA firms exclusive access to professional connections, expert advice and technical resources necessary for overcoming challenges and capitalizing on opportunities.
  • By joining as an affiliate program member, LeaseCrunch will foster meaningful relationships with members, provide valuable resources and actively participate in the organization’s annual event later this year.

Suzy's "The Speed of Culture" Podcast and ADWEEK Renew Partnership Through 2026; Celebrating Milestone 100th Episode

Retrieved on: 
Monday, April 1, 2024
Consumer, Visa, Partnership, News, Marketing, ADWEEK, Commerce, CMO

The partnership, which first took the ADWEEK Podcast Network by storm in 2022, is set for an exciting extension over the next two years, beginning April 1st.

Key Points: 
  • The partnership, which first took the ADWEEK Podcast Network by storm in 2022, is set for an exciting extension over the next two years, beginning April 1st.
  • "ADWEEK is thrilled to renew our partnership with consumer insights platform Suzy and its podcast, The Speed of Culture, for two more years.
  • Together with Suzy, we’re excited to further develop the podcast and grow its audience," said ADWEEK Chief Content Officer Zoe Ruderman.
  • Reflecting on the partnership, Matt Britton shared his enthusiasm: "The collaboration between Suzy and ADWEEK on The Speed of Culture podcast has been an incredible journey.

Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights

Retrieved on: 
Thursday, March 28, 2024
Research, HSV, Assembly, Biotechnology, Partnership, Viral, Doctor of Philosophy, Safety, BeiGene, Simplex, Therapy, CMO

Revenues from collaborative research were $7.2 million for the year ended December 31, 2023.

Key Points: 
  • Revenues from collaborative research were $7.2 million for the year ended December 31, 2023.
  • Research and development expenses were $48.9 million for the year ended December 31, 2023, compared to $70.0 million in 2022.
  • General and administrative expenses were $22.9 million for the year ended December 31, 2023, compared to $24.1 million in 2022.
  • The investigational products and investigational product candidates referenced here have not been approved anywhere globally, and their safety and efficacy have not been established.

Vizit and Salsify Partner to Deliver AI-Powered Conversion Optimizer Application, Elevating Ecommerce Sales to New Heights

Retrieved on: 
Wednesday, March 27, 2024
Ghirardelli Chocolate Company, PXM, Digital, PDP, SKU, Catalog, CMO, Online shopping

The integration of Vizit's AI-powered Conversion Optimizer App into Salsify’s latest platform iteration, Salsify PXM Advance, enables brands to achieve up to a remarkable 10%+ increase in ecommerce sales.

Key Points: 
  • The integration of Vizit's AI-powered Conversion Optimizer App into Salsify’s latest platform iteration, Salsify PXM Advance, enables brands to achieve up to a remarkable 10%+ increase in ecommerce sales.
  • “Both Vizit and Salsify are essential platforms for Ghirardelli’s ecommerce business,” said Pam Perino, Digital Content Operations and Development Manager at Ghirardelli Chocolate Company.
  • PDP conversion optimization: Optimized PDP content drives higher engagement, conversion, and sales through more effective arrangement of product imagery.
  • The Vizit Conversion Optimizer app is built on Vizit’s proprietary AI, which allows brands to “see through the eyes” of their target consumer audiences.